STOCK TITAN

Natera to Participate in the Canaccord Genuity 44th Annual Growth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Natera, a leader in cell-free DNA testing, announced its participation in the Canaccord Genuity 44th Annual Growth Conference. The company's leadership team will present on Wednesday, August 14 at 12:30 PM ET in Boston, MA. Investors and interested parties can access a live webcast of the event through Natera's investor relations website. For those unable to attend, a replay will be available shortly after the conference concludes.

This presentation offers an opportunity for investors to gain insights into Natera's current operations, future strategies, and potential growth prospects. As a key player in the cell-free DNA testing market, Natera's participation in this growth-focused conference may signal important developments or expansion plans for the company.

Natera, leader nel settore dei test del DNA libero, ha annunciato la sua partecipazione al 44° Annual Growth Conference di Canaccord Genuity. Il team dirigenziale dell'azienda presenterà mercoledì 14 agosto alle 12:30 PM ET a Boston, MA. Gli investitori e le parti interessate possono accedere a un webcast dal vivo dell'evento attraverso il sito web delle relazioni con gli investitori di Natera. Per coloro che non possono partecipare, sarà disponibile una registrazione poco dopo la conclusione della conferenza.

Questa presentazione offre un'opportunità agli investitori per ottenere informazioni sulle operazioni attuali di Natera, sulle strategie future e sui potenziali prospetti di crescita. Essendo un attore chiave nel mercato dei test del DNA libero, la partecipazione di Natera a questa conferenza incentrata sulla crescita potrebbe segnalare importanti sviluppi o piani di espansione per l'azienda.

Natera, líder en pruebas de ADN libre, anunció su participación en la 44ª Conferencia Anual de Crecimiento de Canaccord Genuity. El equipo directivo de la empresa hará una presentación el miércoles 14 de agosto a las 12:30 PM ET en Boston, MA. Los inversores y partes interesadas pueden acceder a un webcast en vivo del evento a través del sitio web de relaciones con inversores de Natera. Para aquellos que no puedan asistir, estará disponible una repetición poco después de que concluya la conferencia.

Esta presentación ofrece a los inversores la oportunidad de obtener información sobre las operaciones actuales de Natera, sus estrategias futuras y las posibles oportunidades de crecimiento. Como un jugador clave en el mercado de pruebas de ADN libre, la participación de Natera en esta conferencia centrada en el crecimiento podría indicar desarrollos importantes o planes de expansión para la empresa.

Natera는 세포 자유 DNA 검사 분야의 선두주자로서 Canaccord Genuity 제44회 연례 성장 컨퍼런스에 참여한다고 발표했습니다. 회사의 경영진은 8월 14일 수요일 오후 12:30 ET에 매사추세츠주 보스턴에서 발표할 예정입니다. 투자자와 관심 있는 분들은 Natera의 투자자 관계 웹사이트를 통해 이벤트의 실시간 웹캐스트에 접속할 수 있습니다. 참석할 수 없는 분들을 위해 컨퍼런스 종료 직후 재생이 제공될 예정입니다.

이번 발표는 투자자들이 Natera의 현재 운영, 미래 전략 및 잠재적인 성장 전망에 대한 통찰을 얻을 수 있는 기회를 제공합니다. 세포 자유 DNA 검사 시장의 주요 업체인 Natera의 이번 성장 중심 컨퍼런스 참여는 회사의 중요한 발전이나 확장 계획을 신호하는 것일 수 있습니다.

Natera, leader dans le domaine des tests d'ADN libre, a annoncé sa participation à la 44ème Conférence Annuelle de Croissance de Canaccord Genuity. L'équipe de direction de l'entreprise présentera mercredi 14 août à 12h30 ET à Boston, MA. Les investisseurs et les parties intéressées pourront accéder à un webinaire en direct de l'événement via le site des relations investisseurs de Natera. Pour ceux qui ne peuvent pas y assister, une rediffusion sera disponible peu après la fin de la conférence.

Cette présentation offre aux investisseurs une occasion d'obtenir des informations sur les opérations actuelles de Natera, ses stratégies futures et ses perspectives de croissance potentielles. En tant qu'acteur clé sur le marché des tests d'ADN libre, la participation de Natera à cette conférence axée sur la croissance pourrait signaler des développements importants ou des plans d'expansion pour l'entreprise.

Natera, ein führendes Unternehmen im Bereich der zellfreien DNA-Tests, hat seine Teilnahme an der 44. jährlichen Wachstums-Konferenz von Canaccord Genuity angekündigt. Das Führungsteam des Unternehmens wird am Mittwoch, den 14. August um 12:30 PM ET in Boston, MA, präsentieren. Investoren und interessierte Parteien können über die Investor-Relations-Website von Natera auf einen Live-Webcast der Veranstaltung zugreifen. Für diejenigen, die nicht teilnehmen können, wird kurz nach dem Ende der Konferenz eine Aufzeichnung verfügbar sein.

Diese Präsentation bietet den Investoren die Möglichkeit, Einblicke in die aktuellen Geschäftstätigkeiten, zukünftigen Strategien und potenziellen Wachstumsaussichten von Natera zu gewinnen. Als Schlüsselakteur im Markt für zellfreie DNA-Tests könnte die Teilnahme von Natera an dieser wachstumsorientierten Konferenz wichtige Entwicklungen oder Expansionspläne für das Unternehmen signalisieren.

Positive
  • None.
Negative
  • None.

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that members of its leadership team will present at the Canaccord Genuity 44th Annual Growth Conference on Wednesday, Aug. 14 at 12:30 pm ET | 9:30 am PT in Boston, MA.

A live webcast and audio archive of the event may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of the event will be available shortly following the conference.

About Natera

Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health, and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 200 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. For more information, visit www.natera.com.

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350, investor@natera.com

Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com

Source: Natera, Inc.

FAQ

When is Natera presenting at the Canaccord Genuity Growth Conference?

Natera (NTRA) is presenting at the Canaccord Genuity 44th Annual Growth Conference on Wednesday, August 14 at 12:30 PM ET / 9:30 AM PT.

How can investors access Natera's presentation at the Canaccord conference?

Investors can access a live webcast of Natera's (NTRA) presentation through the investor relations section of the company's website at investor.natera.com.

Will there be a replay available of Natera's presentation at the Canaccord conference?

Yes, a replay of Natera's (NTRA) presentation at the Canaccord Genuity Growth Conference will be available shortly after the event concludes.

Where is the Canaccord Genuity Growth Conference being held?

The Canaccord Genuity 44th Annual Growth Conference, where Natera (NTRA) is presenting, is being held in Boston, MA.

Natera, Inc.

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Stock Data

16.19B
123.68M
3.7%
98.99%
3.06%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
AUSTIN